兴奋剂药物使用与死亡率之间的关联
John P Morrow1, Undina Moreton2, Tianchen Xu3
1Amgen, Inc. Thousand Oaks, CA.
处方兴奋剂药物,如德克斯胺和甲基酸,与成人死亡风险的增加有关. 在处方这些兴奋剂之前,医疗保健提供者应仔细评估心血管健康状况,特别是对老年患者.
科学领域:
- 药物监督和药物流行病学
- 药物的心血管安全性
- 公共卫生研究 公共卫生研究
背景情况:
- 处方兴奋剂被广泛用于诸如ADHD等疾病.
- 人们对这些药物的心血管安全存在担忧.
- 需要大规模的数据分析来评估死亡风险.
研究的目的:
- 调查处方兴奋剂使用与死亡率之间的关联.
- 分析来自FDA不良事件报告系统 (FAERS) 和电子健康记录 (EHR) 的数据.
- 评估大都市医疗保健中心成年患者的风险.
主要方法:
- 进行了两个分析:FAERS数据和EHR数据使用自控病例系列 (SCCS) 方法.
- FAERS分析使用倾向性得分匹配将刺激剂与控制药物的突然死亡事件进行了比较.
- 在SCCS分析中,评估了在个人中启动兴奋剂后所有原因的死亡风险.
主要成果:
- 在FAERS分析中,兴奋剂 (德克斯胺,甲基酸和兴奋剂类) 与突然死亡有显著的相关性.
- 在SCCS分析中,这些兴奋剂也与全因死亡率有显著的关联.
- 对于大多数兴奋剂来说,第一次使用兴奋剂时的死亡风险随年龄增加.
结论:
- 经证实了兴奋剂使用与死亡率之间的显著关联.
- 在处方兴奋剂之前,加强了评估心血管疾病和风险因素的现有指南.
- 建议对开始兴奋剂治疗的老年人特别谨慎.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
相关概念视频
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Abuse and Addiction: Pharmacological Phenomena
